BioSpace News Archive

Appointment of Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience as President of Botanix

The NIH program aims to recruit up to 15 investigators from diverse backgrounds each year and to provide the investigators with mentoring and other professional development activities.

Former commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, although not running for office (that we are aware of), recently published commentary urging the United States to avoid making it more difficult for poor people to gain access to cutting-edge medications.

Polyphor AG announced that it will present new clinical data on survival outcomes of the Phase I trial of balixafortide, our lead immuno-oncology candidate, in combination with eribulin in HER2 negative metastatic breast cancer at the 2019 American Society of Clinical Oncology Annual Meeting being held in Chicago, May 31 - June 4, 2019.

Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESOC 2019

Masy BioServices announced it is expanding its validation services in North Carolina’s Research Triangle Park.

NAYZILAM was approved to treat frequent seizure cluster episodes in epilepsy patients.

The new exploratory data indicated that a larger proportion of patients receiving Entyvio had a clinical response at week 14 compared to those receiving Humira.

The decision, which is likely to be appealed, will allow Dana-Farber to license the technology.

Tom Richardson, president of ILSE, told BioSpace that it’s a shame how New Jersey is often overlooked as a life sciences hub, particularly when a quick glance at the state’s ecosystem reveals the extensive presence of pharma, biotech and other assets of the industry.